UCSF Addiction Conference 2025

• Target Audience: addiction therapist
• Sample video: contact me for sample video
• Information:

The 5th Annual UCSF Addiction CME Conference aims to increase the core competency of medical teams in the inpatient and outpatient settings to improve care for patients who use drugs and alcohol. This conference will increase skills in diagnosis, assessment, and treatment of common substance use disorders through didactics taught by local addiction experts, as well as small group discussions to apply this knowledge to patient care. This is a Virtual Conference.

Target Audience

Physicians

Nurse practitioners and Physician Associates (PAs)

Topics Covered

Keynote address from a person with lived experience of Substance Use Disorder (SUD)

SUD as a brain disease, stigma

Opioid Use Disorder, including starting buprenorphine and methadone

Alcohol use disorder

Benzodiazepine use disorder and withdrawal management

Stimulant use disorder

Pregnancy and SUDs

Pain and SUDs

Hospital based care for patients with SUDs

Communication and documentation in caring for patients with SUDs

Objectives

Attendees completing this course will be able to:

Apply new knowledge in practice to more often recognize signs of substance use disorders (SUDs)

Implement screening in practice to confirm SU

Consider a broader set and combination of evidence-based treatments for opioid, alcohol, and stimulant use disorders in management of SU

• Topics:

*Note: these are continuous video recordings during the conference, they include individual lectures mentioned in the Detail section below

10_Dianna Coffa – Communication with Patients.pdf

11_Tauheed Zaman – Benzodiazepine.pdf

12_Alex Logan – Hospital Based Care.pdf

13_Hannah Snyder – Telehealth and Patient Centered Documentation.pdf

14 _Case 2- AUD, Stim UD, Benzo UD_PARTICIPANT.docx

16_Mishka Terplan – Pregnancy and SUD.pdf

17_Elizabeth Abbs – Controlled Medication Management.pdf

2_Johanna Sluser – Stigma and Clinical Diagnosis of SUD.pdf

3_VERSION 2_Khaled Moussawi_SUD as a Brain Disease.pdf

4 _Andy Tompkins – OUD Diagnosis and Methadone Induction.pdf

5_Christy Soran – Complex Buprenorphine Inductions.pdf

6_Case 1- OUD_PARTICIPANT.docx

8_ Ayesha Appa – Stimulant Use Disorder Treatment.pdf

9_ Triveni Defries – Alcohol Use Disorder.pdf

April 17 AM.mp4

April 17 PM.mp4

April 18 AM.mp4

April 18 PM.mp4

Syllabus Introduction_MDM25P05.pdf

* Detail:

Day 1: April 17, 2025

Welcome from the Conference Co-Chairs: Jesse Ristau*, MD and Alex Logan*, MD

Jose P, Drug and Alcohol Counselor

Drug Treatment Program

Keynote Address

Johanna Sluser*, FNP-C, CARN-AP

Hospital medicine, Psychiatry

Stigma and clinical diagnosis of SUD

Khaled Moussawi, MD, PhD – University of California San Francisco

Neurology

SUD as a brain disease

Break – 15 mins

Andy Tompkins*, MD

Psychiatry, OTP

OUD diagnosis and methadone induction

Christy Soran*, MD, MPH

Primary Care, OBIC

Complex Buprenorphine Inductions

Small Groups

Case 1: OUD diagnosis and treatment

Jesse Ristau*, MD

Primary Care, Inpatient Consult

Break – 15 mins

Ayesha Appa*, MD

Internal Medicine

Stimulants, drug involved deaths

Triveni Defries*, MD

Internal Medicine

Alcohol Use Disorder: Diagnosis and Treatment

Closing

Day 2: April 18, 2025

Introductions: Jesse Ristau*, MD and Alex Logan*, MD

Dianna Coffa*, MD

Family & Community Medicine, ZSFG

Communication with patients who use substances

Tauheed Zaman*, MD

Psychiatry, SFVA

Benzodiazepine Use disorder and detoxification

Break – 15 mins

Alex Logan*, MD

Hospital Medicine

Hospital based care for patients with SUD including Opioid Withdrawal Management

Hannah Snyder*, MD

Family & Community Medicine, ZSFG

Telehealth and Patient Centered Documentation

Small Groups

Case 2: Complex care inpt, outpt, multiple substances, utox (includes 5min of transition time)

Jessica Ristau*, MD

Primary care and Inpatient consult

Break – 15 mins

Mishka Terplan*, MD

OB/GYN

Pregnancy and SUD

Elizabeth Abbs*, MD

Internal Medicine

Controlled medication management and SUD

Closing